Reaction Details Report a problem with these data
Target
fMet-Leu-Phe receptor
Ligand
BDBM37725
Substrate
n/a
Meas. Tech.
Dose Response Assay for Formylpeptide Receptor (FPR) Ligands and Dose Response Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands
Ki
6100±n/a nM
Citation
 PubChem, PC Dose Response Assay for Formylpeptide Receptor (FPR) Ligands and Dose Response Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands PubChem Bioassay (2007)[AID] 
Target
Name:
fMet-Leu-Phe receptor
Synonyms:
FPR | FPR1 | FPR1_HUMAN | Formyl peptide Receptor | N-formyl peptide receptor 1 | N-formylpeptide chemoattractant receptor | fMLP receptor | fMet-Leu-Phe receptor | formyl peptide receptor 1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
38456.14
Organism:
Homo sapiens (Human)
Description:
gi_4503779
Residue:
350
Sequence:
METNSSLPTNISGGTPAVSAGYLFLDIITYLVFAVTFVLGVLGNGLVIWVAGFRMTHTVTTISYLNLAVADFCFTSTLPFFMVRKAMGGHWPFGWFLCKFVFTIVDINLFGSVFLIALIALDRCVCVLHPVWTQNHRTVSLAKKVIIGPWVMALLLTLPVIIRVTTVPGKTGTVACTFNFSPWTNDPKERINVAVAMLTVRGIIRFIIGFSAPMSIVAVSYGLIATKIHKQGLIKSSRPLRVLSFVAAAFFLCWSPYQVVALIATVRIRELLQGMYKEIGIAVDVTSALAFFNSCLNPMLYVFMGQDFRERLIHALPASLERALTEDSTQTSDTATNSTLPSAEVELQAK
  
Inhibitor
Name:
BDBM37725
Synonyms:
2-[[3-(5-chloranyl-2-methoxy-phenyl)-7-oxidanylidene-2-sulfanylidene-4H-[1,3]thiazolo[4,5-d]pyrimidin-5-yl]sulfanyl]-N-(oxolan-2-ylmethyl)ethanamide | 2-[[3-(5-chloro-2-methoxy-phenyl)-7-keto-2-thioxo-4H-thiazolo[4,5-d]pyrimidin-5-yl]thio]-N-(tetrahydrofurfuryl)acetamide | 2-[[3-(5-chloro-2-methoxyphenyl)-7-oxo-2-sulfanylidene-4H-[1,3]thiazolo[4,5-d]pyrimidin-5-yl]sulfanyl]-N-(oxolan-2-ylmethyl)acetamide | 2-[[3-(5-chloro-2-methoxyphenyl)-7-oxo-2-sulfanylidene-4H-thiazolo[4,5-d]pyrimidin-5-yl]thio]-N-(2-oxolanylmethyl)acetamide | 2-{[3-(5-chloro-2-methoxyphenyl)-7-oxo-2-thioxo-2,3,6,7-tetrahydro[1,3]thiazolo[4,5-d]pyrimidin-5-yl]thio}-N-(tetrahydrofuran-2-ylmethyl)acetamide | MLS000095480 | SMR000031034 | cid_3241209
Type:
Small organic molecule
Emp. Form.:
C19H19ClN4O4S3
Mol. Mass.:
499.027
SMILES:
COc1ccc(Cl)cc1-n1c2nc(SCC(=O)NCC3CCCO3)[nH]c(=O)c2sc1=S |(22.17,.5,;20.66,.18,;19.63,1.33,;20.11,2.79,;19.08,3.94,;17.57,3.62,;16.54,4.77,;17.09,2.16,;18.12,1.01,;17.64,-.45,;16.19,-.92,;14.85,-.15,;13.52,-.92,;12.19,-.15,;10.85,-.92,;9.52,-.15,;9.52,1.39,;8.18,-.92,;6.85,-.15,;5.52,-.92,;5.36,-2.45,;3.85,-2.77,;3.08,-1.44,;4.11,-.29,;13.52,-2.46,;14.85,-3.23,;14.85,-4.77,;16.19,-2.46,;17.64,-2.93,;18.54,-1.69,;20.08,-1.69,)|
Structure:
Search PDB for entries with ligand similarity: